Analytical Data
-
Gene name
FAM100A
- Application
-
Alternative Names
UBALD1; FAM100A; PP11303UBA-like domain-containing protein 1
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8TB05
-
Expression Region
1-177aa
-
AA Sequence
MSVNMDELKH QVMINQFVLT AGCAADQAKQ LLQAAHWQFE TALSAFFQET NIPYSHHHHQ MMCTPANTPA TPPNFPDALT MFSRLKASES FHSGGSGSPM AATATSPPPH FPHAATSSSA ASSWPTAASP PGGPQHHQPQ PPLWTPTPPS PASDWPPLAP QQATSEPRAH PAMEAER
-
Molecular Weight
45.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM100A, also known as FAM100A protein or FAM100A homolog, is a member of the FAM100 protein family, characterized by its critical roles in cellular proliferation, differentiation, and apoptosis. Research has highlighted its potential involvement in various diseases, particularly cancer, where aberrant expression of FAM100A correlates with tumor progression and metastasis. Studies suggest that FAM100A may function as a regulator of key signaling pathways, including those related to cell cycle control and stress responses, which could explain its contribution to oncogenic processes. Furthermore, the interrogation of FAM100A's structure and function has the potential to uncover novel therapeutic targets. The recombinant expression of FAM100A protein enables researchers to perform detailed biochemical studies, elucidating its molecular interactions and biological functions. This research is crucial for understanding the precise mechanisms by which FAM100A influences cellular behavior and could pave the way for innovative strategies in cancer treatment and other diseases linked to its dysregulation. As interest in this protein continues to grow, ongoing studies will likely explore its roles in development and cellular homeostasis, solidifying FAM100A's status as a significant player in both basic and applied biomedical research.
